RLAY

Relay Therapeutics Inc.

Price

$20.74

return (12m)

510.00%

p/e

-14.05

p/bv

4.52

DIVIDEND YIELD

0.00%

RLAY price

Relay Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment RLAY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

4.56%

3 months

51.83%

1 year

510.00%

2 years

186.86%

5 years

-34.22%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals RLAY

Valuation

P/E

-14.05

Sector -4.38

Industry -4.38

P/BV

4.52

Sector 2.02

Industry 2.02

P/Revenue (PSR)

388.35

Sector -4.40

Industry -4.40

EV/EBITDA

-34.36

Sector -263.09

Industry -263.09

EV/EBIT

-34.23

Sector -702.90

Industry -702.90

P/EBITDA

-13.04

Sector -4.39

Industry -4.39

P/EBIT

-12.95

Sector -4.73

Industry -4.73

P/Total Assets

4.15

Sector 1.49

Industry 1.49

P/Net Current Assets

4.73

Sector -11.70

Industry -11.70

P/Working Capital

4.58

Sector -3.19

Industry -3.19

EPS

-1.41

Sector -2.14

Industry -2.14

BVPS

4.38

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

100.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-25,845.71%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-25,948.57%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-32.14%

Sector -65.14%

Industry -65.14%

ROA

-29.57%

Sector -65.53%

Industry -65.53%

ROIC

-802.62%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

18.27

Sector 2.90

Industry 2.90

Net Debt / EBITDA

10.07

Sector -6.07

Industry -6.07

Net Debt / EBIT

10.03

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.02

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.92

Sector 0.41

Industry 0.41

Liabilities/Assets

0.08

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

27.85%

Sector -

Industry -

5Y Earnings CAGR

-4.70%

Sector -

Industry -

Fundamentals RLAY

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
RLAY Relay Therapeutics Inc.	$20.74	497.69%	0.00%	-14.05	4.52	-32.14%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

RLAY Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Relay Therapeutics

Relay Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

11 years

Founded: 2015

2020

Time since IPO - 6 years

159

Employees

Relay Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $4.02 billion, with shareholders equity totaling $890.01 million.

The company employs approximately 159 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Relay Therapeutics Inc. reported $10.35 million in revenue, generating net income of $-286.04 million.

Key financial metrics include a P/E ratio of -14.05, a price-to-book (P/B) ratio of 4.52, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker RLAY.

Market cap

$4.02 billion

Net worth

$890.01 million

$890,010,000.00

Assets

$967.46 million

$967,460,000.00

Total Shares Outstanding

203.00 million

203,000,000

Average Daily Trading Volume

$3.32 million

$3,321,067.70

Sector

Health Care

Industry

Biotechnology

RLAY

RLAY revenue and profits

Financial Results RLAY

DRAG THE FRAME TO SEE MORE DATA

RLAY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Relay Therapeutics (RLAY) today?

A cotação de Relay Therapeutics (RLAY) hoje está em US$ 20.74, com uma variação de 510% em relação ao último ano. A cotação de Relay Therapeutics (RLAY) iniciou o ano negociando na casa dos US$ 8.46 e hoje está em US$ 20.74. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Relay Therapeutics (RLAY) e dados de ações do Ibovespa e mercados internacionais.

Quando Relay Therapeutics (RLAY) paga dividendos?

Relay Therapeutics (RLAY) não distribuiu dividendos no último ano.

Is Relay Therapeutics (RLAY) a good investment?

Atualmente, Relay Therapeutics (RLAY) está cotada a US$ 20.74, com um P/L de -14.05, representando um desvio de -632% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 510 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 510.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Relay Therapeutics (RLAY) stock?

Investir em ações de Relay Therapeutics (RLAY) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Relay Therapeutics (RLAY) yield today?

A rentabilidade de Relay Therapeutics (RLAY) foi de 4.56% no último mês, 510.00% no último ano e -34.22% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Relay Therapeutics (RLAY) hoje, o investimento total seria de US$ 2,074.00, com base na cotação atual de US$ 20.74.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 12,651.40
Em 5 anos: US$ 1,364.28
Em 10 anos: US$ 2,074.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

RLAY

Relay Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment RLAY

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING RLAY WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Relay Therapeutics

Relay Therapeutics Inc.

United States

11 years

2020

159

PROFIT X PRICE RLAY

Financial Results RLAY

RLAY cash flow

Asset, Revenue and Profit Growth - RLAY

RLAY balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions